RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems.
Based outside Boston, Massachusetts, the company supports customers using RainDrop Plus™ Digital PCR and ThunderStorm® Next-Generation Sequencing Target Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and ThunderStorm System in 2011.
RainDance Technologies is leading a transformation in disease research by making innovative tools that simplify complex genetic analysis. We are focused on delivering innovative Digital Droplet-based solutions that fundamentally enhance the way researchers and scientists study cell-based and cell-free biomarkers in cancer, infectious disease and inherited disorders. Our mission is to democratize and simplify genetic analysis across the full continuum from hereditary risk predisposition, initial detection, pathology and progression, and residual disease monitoring.
Over the past year, we have seen broad adoption of our RainDrop Plus™ Digital PCR System, ThunderStorm® NGS Target Enrichment System and theThunderBolts™ System. Globally, our customers include: leading academic and translational research institutions, cancer centers, bio-banks, commercial laboratories, pharmaceutical and biotechnology companies, agricultural and industrial clients, and government institutions.